研究单位：[1]Beijing InnoCare Pharma Tech Co., Ltd.[2]The first affiliated hospital of bengbu medical college,Bengbu,Anhui,China,233099[3]The First Affiliated Hospital of Anhui Medical University,Hefei,Anhui,China,230022[4]Peking University People's Hospital,Beijing,Beijing,China,100000[5]China-Japan Friendship Hospital,Beijing,Beijing,China,100029[6]Beijing Friendship Hospital, Capital Medical University,Beijing,Beijing,China,100050[7]The First Affiliated Hospital of XiaMen University,Xiamen,Fujian,China,361009[8]The First Affiliated Hospital,Sun Yat-sen University,Guangzhou,Guangdong,China,510080[9]The Seventh Affiliated Hospital, Sun Yat-sen University,Shenzhen,Guangdong,China,518107[10]Affiliated Hospital of Guilin Medical University,Guilin,Guangxi Zhuang Autonomous Region,China,541001[11]Affiliated Hospital of HeBei University,Baoding,Hebei,China,071030[12]Hebei People's Hospital,Shijiazhuang,Hebei,China,050051[13]Daqing Oilfield General Hospital,Daqing,Heilongjiang,China,Contact: Junsong Li[14]The first hospital of Qiqihar,Qiqihar,Heilongjiang,China,161005[15]The First Affiliated Hospital of Henan University of Science and Technology,Luoyang,Henan,China,471003[16]First Affiliated Hospital of Zhengzhou University,Zhengzhou,Henan,China,450052[17]Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology,Wuhan,Hubei,China,430022[18]The Second XIANGYA Hospital Of Central South University,Changsha,Hunan,China,410000[19]Yiyang Central Hospital,Yiyang,Hunan,China,413000[20]Zhuzhou Central Hospital,Zhuzhou,Hunan,China,412000[21]Xuzhou Central Hospital,Xuzhou,Jiangsu,China,221000[22]Jiujiang NO.1 People's Hospital,Jiujiang,Jiangxi,China,332000[23]The First Affiliated Hospital of Nanchang University,Nanchang,Jiangxi,China,330006[24]Jilin Provincial People's Hospital,Changchun,Jilin,China,130021[25]Shengjing Hospital of china medical university,Shenyang,Liaoning,China,110004[26]Affiliated Hospital of Inner Mongolia Medical University,Hohhot,Nei Monggol Autonomous Region,China,010000[27]Affiliated Hospital of Binzhou Medical College,Binzhou,Shandong,China,256699[28]Jining First People's Hospital,Jining,Shandong,China,272002[29]Linyi People's Hospital,Linyi,Shandong,China,276034[30]Changhai Hospital of Shanghai,Shanghai,Shanghai,China,200000[31]Renji Hospital, Shanghai Jiao Tong University School of Medicine,Shanghai,Shanghai,China,200000[32]The First Hospital of Shanxi Medical University,Taiyuan,Shanxi,China,030001[33]The Second Hospital of Shanxi Medical University,Taiyuan,Shanxi,China,030001[34]The First Affiliated Hospital of Xi 'an Jiaotong University,Xi'an,Shanxi,China,710061[35]Tianjin Medical University General Hospital,Tianjin,Tianjin,China,300000[36]Xinjiang Uygur Autonomous Region People's Hospital,Ürümqi,Xinjiang,China,830000[37]The Third People's Hospital of Huzhou,Huzhou,Zhejiang,China,313002[38]The First Hospital of Ningbo,Ningbo,Zhejiang,China,315010[39]The First People's Hospital of Wenling,Wenling,Zhejiang,China,317500[40]Wenzhou People's Hospital,Wenzhou,Zhejiang,China,325099
研究目的：
This is a phase IIb, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of orelabrutinib in adult subjects with SLE who are receiving standard of care (SOC) therapy.
